Distressed Arcadia Biosciences Closes $4M Private Placement, Bolstering Liquidity
RKDA sits 22% above its 52-week low of $0.8.
Summary
Arcadia Biosciences announced the closing of its $4 million private placement, selling common stock and warrants at $1.03 per share. This follows the announcement of the placement yesterday and comes after the company reported a Q1 net loss of $4.4 million, a going concern warning, and a $4.0 million debt default in May. The $4 million in gross proceeds is a critical capital injection, significantly exceeding the company's current market capitalization, and provides essential liquidity for its continued operations.
At the time of this announcement, RKDA was trading at $0.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $0.80 to $6.71. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.